Prod1.novartis.com

Novartis US Foundation commits $25M to improve health equity …

WEB"In the wake of the COVID-19 pandemic and heightened attention on racial injustice in the US, there has been new and significant recognition of disparities in care …

Actived: Just Now

URL: https://prod1.novartis.com/us-en/news/media-releases/novartis-us-foundation-commits-25m-improve-health-equity-reducing-health-disparities-us

About Novartis United States of America

WEBExternal Funding Novartis is reimagining medicine to improve and extend people’s lives. We provide financial support for educational, advocacy, and outreach activities that help …

Category:  Medicine Go Health

FDA approves Novartis Kymriah® CAR-T cell therapy for adult …

WEB68% of patients receiving Kymriah in the ELARA trial experienced complete response, with an 86% overall response rate, along with a remarkable safety profile1Sustained clinical …

Category:  Health Go Health

Novartis receives FDA approval for BEOVU®, offering wet AMD …

WEBIn two head-to-head clinical trials, patients on BEOVU (brolucizumab-dbll) achieved vision gains that were non-inferior to aflibercept at year one with longer …

Category:  Health Go Health

FDA approves Novartis Leqvio® (inclisiran), first-in-class siRNA to

WEBJulie Masow: Jamie Bennett: Head, US External Engagement: Director, US External Engagement +1 862 579 8456 +1 862 217 3976 [email protected] [email …

Category:  Health Go Health

Novartis in the US Novartis United States of America

WEBNovartis in the US. At Novartis, we are reimagining medicine to improve and extend people’s lives. We are working hard to produce breakthroughs and address unmet …

Category:  Medicine Go Health

Global health Novartis

WEBAt Novartis, we have a long-standing history in addressing global health challenges. Over the past 20 years, our approach has evolved from purely donation-based toward models …

Category:  Health Go Health

Novartis United States of America

WEBNovartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide. At Novartis, we reimagine medicine in …

Category:  Medicine Go Health

Novartis radioligand therapy Lutathera® FDA approved as first …

WEBApproval based on NETTER-P trial in which Lutathera demonstrated a consistent safety profile and comparable drug exposure between pediatric (ages 12-17) …

Category:  Health Go Health

Cardiovascular disease – By the Numbers Novartis

WEBAbout. Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals …

Category:  Medicine Go Health

Novartis Kymriah® demonstrates strong responses in high-risk …

WEBPublished on Dec 11, 2021. Disclaimer. This press release contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform …

Category:  Health Go Health

Global Health disease area research at Novartis Novartis

WEBAddressing poverty-related and neglected diseases. Malaria, diarrheal disease, and “tropical” infections such as dengue and visceral leishmaniasis are among many …

Category:  Health Go Health

Novartis receives FDA approval for Fabhalta® (iptacopan), offering

WEBApproval based on APPLY-PNH trial in adults with PNH and anemia despite prior anti-C5 treatment, and supported by the APPOINT-PNH study in complement …

Category:  Health Go Health

Novartis patient support for oncology Novartis United States of …

WEBNovartis Patient Support is a comprehensive program designed to help you start, stay, and save on treatment. You can sign up once your health care provider prescribes you or …

Category:  Health Go Health

Research and Development Novartis United States of America

WEBResearch and Development. In 2019, Novartis invested USD 3.9 billion in US-based research and development (R&D), representing more than 41% of our global R&D …

Category:  Health Go Health

Novartis expands production of Pluvicto® with addition of its …

WEBFDA approval of the company’s second US Radioligand Therapy (RLT) manufacturing facility increases RLT production capacity to 250,000 doses in 2024 and …

Category:  Health Go Health

Coronavirus Novartis

WEBCoronavirus disease. Novartis has been responding to the coronavirus disease (COVID-19) with safety of associates and patients globally as our primary concern. We have been …

Category:  Coronavirus Go Health

Novartis accelerates efforts toward ESG targets to increase access …

WEBReached nearly 29 million patients to date in 2021 through our flagship programs and strategic innovative brands; Announced a planned 10-year commitment …

Category:  Health Go Health

Career Search Novartis United States of America

WEBCareer search. Explore opportunities with Novartis below. Notice to applicants for US job openings. EEO (PDF 0.1 MB) | Pay Transparency (PDF 0.1 MB) Function. Audit & …

Category:  Health Go Health

APPIS 2024: Healthcare Stakeholders Come Together to Prioritize …

WEBThe 4th annual Alliance & Partnerships for Patient Innovation & Solutions (APPIS) Summit will take place on Tuesday, March 19, and Wednesday, March 20, …

Category:  Health Go Health